BioNTech SE ADR BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs,…
Read more BNTX Stock Price | BioNTech SE ADR Stock Quote (U.S.: Nasdaq) | MarketWatchIt may be time to get your COVID-19 vaccine again. There’s a new booster that’s coming out to guard against the virus. The Centers for Disease Control and…
Read more 5 things to know about the new COVID-19 vaccineThe Centers for Disease Control and Prevention on Tuesday recommended updated COVID-19 vaccines for people 6 months of age and older. Director Mandy Cohen late Tuesday backed the…
Read more CDC recommends updated COVID shots for people 6 months of age and olderBioNTech SE ADR BioNTech SE engages in the development of novel medicines at the intersection of immunology and synthetic biology. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac,…
Read more BNTX Stock Price | BioNTech SE ADR Stock Quote (U.S.: Nasdaq) | MarketWatchThe World Health Organization has called on China to release more information about its current wave of COVID infections after China said nearly 60,000 people have succumbed to…
Read more WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulatingThe XBB.1.5 omicron subvariant that has been dominant in the Northeast for several weeks is now officially dominant across the U.S., according to an update from the Centers…
Read more New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC saysChina on Tuesday suspended visas for South Koreans to enter the country for tourism or business in apparent retaliation for South Korea’s COVID-19 testing requirements for Chinese travelers, the…
Read more China takes first steps to punish countries that imposed testing mandates for Chinese travelersCOVID-19 cases are once again rising in the U.S., but how prepared are we for the next pandemic? That’s a question worth asking. The $1.7 trillion omnibus spending…
Read more Federal spending bill’s pandemic provisions: more public health data, no investigation into COVID’s originOmicron subvariants continued to account for more new cases of COVID-19 in the U.S. in the latest week than did BA.5, according to the latest data from the…
Read more Omicron subvariants are now dominant in the U.S. as COVID cases tick up and New York City becomes a hot spotThe Food and Drug Administration on Thursday authorized the bivalent COVID-19 boosters made by Moderna Inc. MRNA, +3.18% and BioNTech SE BNTX, +5.64% /Pfizer Inc. PFE, +3.07% for…
Read more FDA to allow bivalent COVID boosters for some infants and young childrenThe head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus pandemic as the…
Read more IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderlyWidespread protests across China over the government’s zero-COVID policy dominated pandemic headlines Monday, with Anthony Fauci, President Joe Biden’s chief medical adviser, weighing in with the view that…
Read more China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says FauciAs we head into the third winter of the pandemic, only about 13% of American adults — less than 11% of Americans overall — have received the bivalent…
Read more Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech…
Read more Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of dataThe head of the World Health Organization said a close to 90% decline in COVID deaths globally compared to nine months ago is “cause for optimism,” but urged…
Read more WHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variantsChina’s strict zero-COVID policy was making headlines Monday after Apple and iPhone manufacturer Foxconn said over the weekend that restrictions are crimping production and will delay shipments of…
Read more All eyes on China as Apple and Foxconn outline zero-COVID issues. Meanwhile, cases are rising again in the U.S.First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher” immune response in…
Read more Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a dayThe Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that the authority for…
Read more CDC shoots down false claims it will mandate COVID-19 vaccines for schoolchildren, saying states make that decisionPfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110 to $130 per dose once…
Read more Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per doseThe Centers for Disease Control and Prevention said a new COVID variant dubbed BQ.1 and a descendant called BQ.1.1 have gained traction in the U.S., accounting for 11.4%…
Read more CDC identifies new COVID variants that accounted for 11.4% of new cases in week ending Oct. 15
